Hazani H, Naina Mohamed I, Muzaimi M, Mohamed W, Yahaya M, Teoh S
Front Pharmacol. 2022; 13:859563.
PMID: 35462918
PMC: 9021401.
DOI: 10.3389/fphar.2022.859563.
Guerin A, Bonomo Y, Lawrence A, Baune B, Nestler E, Rossell S
Front Psychiatry. 2020; 10:880.
PMID: 31920743
PMC: 6928591.
DOI: 10.3389/fpsyt.2019.00880.
Gutierrez A, Regan S, Hoover C, Williams M, Vorhees C
Psychopharmacology (Berl). 2019; 236(7):2243-2258.
PMID: 30919007
PMC: 6626678.
DOI: 10.1007/s00213-019-05221-3.
Zhang C, Luo T, Liu L, Dong H, Hao W
Front Psychiatry. 2019; 9:698.
PMID: 30618872
PMC: 6299101.
DOI: 10.3389/fpsyt.2018.00698.
Gutierrez A, Williams M, Vorhees C
Neurotox Res. 2018; 33(3):671-680.
PMID: 29427284
PMC: 5874175.
DOI: 10.1007/s12640-018-9871-9.
Early Initiation of Amphetamine-Type Stimulants (ATS) Use Associated with Lowered Cognitive Performance among Individuals with Co-Occurring Opioid and ATS Use Disorders in Malaysia.
Chooi W, Mohd Zaharim N, Desrosiers A, Ahmad I, Yasin M, Syed Jaapar S
J Psychoactive Drugs. 2017; 49(4):326-332.
PMID: 28661714
PMC: 6218246.
DOI: 10.1080/02791072.2017.1342152.
Mephedrone and nicotine: oxidative stress and behavioral interactions in animal models.
Budzynska B, Boguszewska-Czubara A, Kruk-Slomka M, Kurzepa J, Biala G
Neurochem Res. 2015; 40(5):1083-93.
PMID: 25862193
PMC: 4422847.
DOI: 10.1007/s11064-015-1566-5.
An Update of the Review of Neuropsychological Consequences of HIV and Substance Abuse: A Literature Review and Implications for Treatment and Future Research.
Norman L, Basso M
Curr Drug Abuse Rev. 2015; 8(1):50-71.
PMID: 25751583
PMC: 4900459.
DOI: 10.2174/1874473708666150309124820.
Correlates of self-reported incarceration among homeless gay and bisexual stimulant-using young adults.
Nyamathi A, Reback C, Salem B, Zhang S, Shoptaw S, Branson C
West J Nurs Res. 2014; 37(6):799-811.
PMID: 24733231
PMC: 4197114.
DOI: 10.1177/0193945914530521.
The acute effects of 3,4-methylenedioxymethamphetamine and d-methamphetamine on human cognitive functioning.
Stough C, King R, Papafotiou K, Swann P, Ogden E, Wesnes K
Psychopharmacology (Berl). 2011; 220(4):799-807.
PMID: 22020992
DOI: 10.1007/s00213-011-2532-9.
Toward a Better Understanding of Non-Addicted, Methamphetamine-Using, Men who Have Sex with Men (MSM) in Atlanta.
Dew B
Open AIDS J. 2010; 4:141-7.
PMID: 20657718
PMC: 2908926.
DOI: 10.2174/1874613601004030141.
Neuropsychological deficits in adolescent methamphetamine abusers.
King G, Alicata D, Cloak C, Chang L
Psychopharmacology (Berl). 2010; 212(2):243-9.
PMID: 20640405
PMC: 2939179.
DOI: 10.1007/s00213-010-1949-x.
Pharmacological approaches to methamphetamine dependence: a focused review.
Karila L, Weinstein A, Aubin H, Benyamina A, Reynaud M, Batki S
Br J Clin Pharmacol. 2010; 69(6):578-92.
PMID: 20565449
PMC: 2883750.
DOI: 10.1111/j.1365-2125.2010.03639.x.
Khat use and neurobehavioral functions: suggestions for future studies.
Hoffman R, alAbsi M
J Ethnopharmacol. 2010; 132(3):554-63.
PMID: 20553832
PMC: 2976806.
DOI: 10.1016/j.jep.2010.05.033.
Methamphetamine dependence and neuropsychological functioning: evaluating change during early abstinence.
Simon S, Dean A, Cordova X, Monterosso J, London E
J Stud Alcohol Drugs. 2010; 71(3):335-44.
PMID: 20409426
PMC: 2859784.
DOI: 10.15288/jsad.2010.71.335.
Psychiatric symptoms and HPA axis function in adolescent methamphetamine users.
King G, Alicata D, Cloak C, Chang L
J Neuroimmune Pharmacol. 2010; 5(4):582-91.
PMID: 20358305
PMC: 2974768.
DOI: 10.1007/s11481-010-9206-y.
Effect of a neurotoxic dose regimen of (+)-methamphetamine on behavior, plasma corticosterone, and brain monoamines in adult C57BL/6 mice.
Grace C, Schaefer T, Herring N, Graham D, Skelton M, Gudelsky G
Neurotoxicol Teratol. 2010; 32(3):346-55.
PMID: 20096350
PMC: 2854319.
DOI: 10.1016/j.ntt.2010.01.006.
Toxic effect of methamphetamine on the retina of CD1 mice.
Lai H, Zeng H, Zhang C, Wang L, Tso M, Lai S
Curr Eye Res. 2009; 34(9):785-90.
PMID: 19839872
PMC: 2765663.
DOI: 10.1080/02713680903079641.
The neuropsychology of amphetamine and opiate dependence: implications for treatment.
Ersche K, Sahakian B
Neuropsychol Rev. 2007; 17(3):317-36.
PMID: 17690986
PMC: 3639428.
DOI: 10.1007/s11065-007-9033-y.